CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $95,685 | +1813.7% | 10,973 | +631.5% | 0.01% | – |
| Q2 2020 | $5,000 | 0.0% | 1,500 | +95.6% | 0.00% | – |
| Q2 2019 | $5,000 | -37.5% | 767 | -23.7% | 0.00% | – |
| Q4 2018 | $8,000 | -11.1% | 1,005 | +24.1% | 0.00% | -100.0% |
| Q3 2018 | $9,000 | -25.0% | 810 | -10.6% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | +140.0% | 906 | +84.9% | 0.00% | – |
| Q4 2017 | $5,000 | -91.2% | 490 | -93.1% | 0.00% | -100.0% |
| Q3 2017 | $57,000 | – | 7,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |